How should a 150 mg extended‑release (XL) tablet be tapered?

How to Taper 150 mg XL

For a 150 mg extended-release tablet, taper by reducing the dose by 10% per week initially, with slower reductions as you approach lower doses, avoiding abrupt discontinuation to prevent withdrawal symptoms.

Context Clarification

The question "How to taper 150 mg XL?" lacks specificity about the medication class. Based on the evidence provided, I'll address the most common scenarios:

If This is an Antidepressant (e.g., Bupropion XL, Venlafaxine XR)

Start with 10% dose reductions every 2-4 weeks, slowing to smaller decrements as you reach lower doses 1. The key principle is that withdrawal risk increases with smaller absolute doses, requiring progressively gentler reductions.

Practical Tapering Algorithm:

• Week 0-2: 150 mg → 135 mg (10% reduction)
• Week 2-4: 135 mg → 120 mg
• Week 4-6: 120 mg → 105 mg
• Week 6-10: 105 mg → 90 mg (slow down here)
• Continue with smaller reductions: 90 → 75 → 60 → 45 → 30 → 20 → 10 → 5 → 2 → 1 mg before stopping

Critical: Do NOT use alternate-day dosing (e.g., 150 mg every other day). This creates severe fluctuations in drug levels and receptor occupancy, dramatically increasing withdrawal symptoms 2.

High-Risk Patients Requiring Slower Tapering:

• Previous failed taper attempts
• Duration of use >12 months
• Higher doses (though 150 mg is typically mid-range)
• History of withdrawal symptoms
• Drugs with shorter half-lives (venlafaxine, duloxetine, paroxetine) 1

For these patients, use hyperbolic tapering over months to years, reducing to doses as low as 1 mg before complete cessation 3. This requires liquid formulations or compounded preparations 1.

Monitoring Schedule:

• Every 2-4 weeks during active tapering 4
• Watch for withdrawal symptoms: anxiety, irritability, insomnia, flu-like symptoms, electric shock sensations
• Distinguish withdrawal from relapse: Withdrawal symptoms typically emerge within days of dose reduction and improve with dose stabilization; relapse develops more gradually over weeks 4

If This is an Opioid

Reduce by 10% per week initially, adjusting based on tolerance of withdrawal symptoms 5. The 2020 Mayo Clinic guideline recommends this as the standard approach 5.

Opioid-Specific Tapering:

• Initial reduction: 10% of current dose per week 5
• Alternative slower approach: Start with 5% reductions, then continue with 10% decrements over 4 months 5
• Adjust based on patient response: Some patients may need slower tapers; others may tolerate faster reductions

Managing Withdrawal Symptoms:

Use adjuvant medications liberally 5:

• Clonidine: 0.1-0.2 mg every 6 hours OR 0.1 mg transdermal patch weekly 6
• Tizanidine: Start 2 mg at night, increase by 2-4 mg daily up to 8 mg every 8 hours 6
• Provide adequate clinician time and support 5

Critical Warnings:

• Never abruptly discontinue - FDA warning about serious withdrawal symptoms 5
• Expect protracted withdrawal lasting months: dysphoria, irritability, insomnia, anhedonia 5
• Pain may worsen during tapering as a withdrawal symptom, not just disease recurrence 5
• Fear of withdrawal is a major reason for taper failure 5

Common Pitfalls to Avoid

1. Too-rapid tapering: Current guidelines acknowledge that 2-4 week tapers show "minimal benefits over abrupt discontinuation" 3
2. Stopping at "minimum therapeutic doses": Taper to much lower doses (even sub-milligram) to minimize withdrawal 3
3. Alternate-day dosing: Creates dangerous fluctuations 2
4. Inadequate withdrawal symptom management: Address symptoms proactively, not reactively 5
5. Mistaking withdrawal for relapse: Leads to unnecessary long-term medication 4

When to Pause or Reverse the Taper

• Severe withdrawal symptoms emerge
• Patient cannot tolerate current reduction rate
• Functional impairment occurs
• Option to pause, slow down, or temporarily increase dose 4

The evidence consistently shows that slower is safer - prioritize patient tolerability over speed of discontinuation.